-+ 0.00%
-+ 0.00%
-+ 0.00%

*TuHURA Biosciences: Expect to Initiate Phase 1b/2 Trial of VISTA in mutNPM1 R/r AML in 2H 2026 >HURA

Dow Jones·08/14/2026 11:47:00

Please log in to view news